Nakajima S, Hsieh J C, MacDonald P N, Haussler C A, Galligan M A, Jurutka P W, Haussler M R
Department of Biochemistry, College of Medicine, University of Arizona, Tucson 85724.
Biochem Biophys Res Commun. 1993 Dec 15;197(2):478-85. doi: 10.1006/bbrc.1993.2504.
We report here that highly purified human vitamin D receptor (hVDR) derived from E. coli or baculovirus expression systems does not exhibit saturable, high affinity 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) ligand binding when these preparations alone are analyzed. Inclusion of rat liver nuclear extract, which does not itself contain detectable 1,25(OH)2D3 binding activity, is required to endow hVDR isolated from bacterial or insect cells with the property of high affinity hormone binding (Kd = 0.13-0.22 nM). This observation should facilitate the valid assay of 1,25(OH)2D3 binding activity and kinetics in samples of overexpressed hVDR. Moreover, since rat liver nuclear extract contains retinoid X receptors and possibly other auxiliary factors capable of forming heterodimers with hVDR that in turn associate with vitamin D responsive elements, we hypothesize that like DNA binding, 1,25(OH)2D3 binding to hVDR requires the cooperation of a co-receptor or some uncharacterized receptor activating/stabilizing factor.
我们在此报告,当单独分析从大肠杆菌或杆状病毒表达系统获得的高度纯化的人维生素D受体(hVDR)时,其不表现出可饱和的、高亲和力的1,25 - 二羟基维生素D3(1,25(OH)2D3)配体结合。若要赋予从细菌或昆虫细胞分离出的hVDR高亲和力激素结合特性(Kd = 0.13 - 0.22 nM),则需要加入大鼠肝核提取物,而该提取物本身并不含有可检测到的1,25(OH)2D3结合活性。这一观察结果应有助于对过表达hVDR样品中的1,25(OH)2D3结合活性和动力学进行有效的检测。此外,由于大鼠肝核提取物含有视黄酸X受体以及可能其他能够与hVDR形成异源二聚体并进而与维生素D反应元件结合的辅助因子,我们推测,与DNA结合一样,1,25(OH)2D3与hVDR的结合需要共受体或某些未明确的受体激活/稳定因子的协同作用。